SCHEMBL18177582

SCHEMBL18177582

CC(C)(C)c1ccc(Oc2ccn3ncnc3c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
RAB9A P51151 2/20 0.42
HPGD P15428 2/20 0.42
NPC1 O15118 1/20 0.42
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
FGFR2 P21802 1/20 0.39
POLB P06746 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
PTPN2 P17706 1/20 0.36
PTPN1 P18031 1/20 0.36
PIK3CD O00329 1/20 0.36
BCHE P06276 4/20 0.35
ACHE P22303 4/20 0.35
MAPK14 Q16539 1/20 0.35
ADAMTS5 Q9UNA0 1/20 0.34
EGFR P00533 2/20 0.34
ERBB2 P04626 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30613048 0.84 PIK3CD (0.40) PIK3CDEGFRERBB2NQO2FECH
SCHEMBL12261810 0.84 ERBB2 (0.45) KDM4EKMT2AEGFRERBB2NQO2
SCHEMBL18181595 0.84 TEAD4 (0.38) ALDH1A1MAPTPOLBMEN1KMT2A
SCHEMBL15703717 0.82 CYP2C19 (0.40) ALDH1A1HPGDKDM4EEGFRERBB2
SCHEMBL12872519 0.81 ALDH1A1 (0.44) ALDH1A1RAB9ANPC1MAPTMAPK1
SCHEMBL12261806 0.75 ALDH1A1 (0.44) ALDH1A1RAB9AHPGDNPC1MAPT
SCHEMBL26005853 0.75 ALDH1A1 (0.46) ALDH1A1RAB9ANPC1MAPTMAPK1
SCHEMBL21563376 0.75 PIK3CD (0.47) ALDH1A1KDM4EPIK3CDEGFRERBB2
SCHEMBL13185122 0.75 ERBB2 (0.43) EGFRERBB2NQO2FECHMYH14
SCHEMBL25177224 0.73 NR4A1 (0.36) ALDH1A1PIK3CDEGFRERBB2NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160311780-A1 HETEROARYL COMPOUNDS AND USES THEREOF CELGENE AVILOMICS RES INC (US) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311780-A1 HETEROARYL COMPOUNDS AND USES THEREOF ABCG2, CYP3A43, CYP3A5 ALDH1A1 684/4885RAB9A 580/4885HPGD 1580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.